These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 25847683)
1. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression. Li C; Wang W; Xie L; Luo X; Cao X; Wan M Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683 [TBL] [Abstract][Full Text] [Related]
2. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction. Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935 [TBL] [Abstract][Full Text] [Related]
3. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism. Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415 [TBL] [Abstract][Full Text] [Related]
4. Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation. Baertschi S; Baur N; Lueders-Lefevre V; Voshol J; Keller H J Biol Chem; 2014 Sep; 289(36):24995-5009. PubMed ID: 25012661 [TBL] [Abstract][Full Text] [Related]
5. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759 [TBL] [Abstract][Full Text] [Related]
6. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
7. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone. Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589 [TBL] [Abstract][Full Text] [Related]
8. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice. Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116 [TBL] [Abstract][Full Text] [Related]
9. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646 [TBL] [Abstract][Full Text] [Related]
11. Antagonists of LRP6 regulate PTH-induced cAMP generation. Shi C; Li J; Wang W; Cao W; Cao X; Wan M Ann N Y Acad Sci; 2011 Nov; 1237():39-46. PubMed ID: 22082363 [TBL] [Abstract][Full Text] [Related]
12. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action. Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803 [TBL] [Abstract][Full Text] [Related]
13. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone. Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022 [TBL] [Abstract][Full Text] [Related]
14. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes. Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454 [TBL] [Abstract][Full Text] [Related]
15. Does osteocytic SOST suppression mediate PTH bone anabolism? Kramer I; Keller H; Leupin O; Kneissel M Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973 [TBL] [Abstract][Full Text] [Related]
16. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Bonnet N; Conway SJ; Ferrari SL Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15048-53. PubMed ID: 22927401 [TBL] [Abstract][Full Text] [Related]
17. SOST is a target gene for PTH in bone. Keller H; Kneissel M Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907 [TBL] [Abstract][Full Text] [Related]
18. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor. Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638 [TBL] [Abstract][Full Text] [Related]
19. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats. Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352 [TBL] [Abstract][Full Text] [Related]
20. Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D St John HC; Hansen SJ; Pike JW J Steroid Biochem Mol Biol; 2016 Nov; 164():277-280. PubMed ID: 26361013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]